We are live on ! Find out more
EIS icon

iShares MSCI Israel ETF

79 hedge funds and large institutions have $58.3M invested in iShares MSCI Israel ETF in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.64% less ownership

Funds ownership: 33.4%31.76% (-1.6%)

10% less funds holding

Funds holding: 8879 (-9)

18% less capital invested

Capital invested by funds: $70.8M → $58.3M (-$12.5M)

19% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 21

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
79
Holders Change
-9
Holders Change %
-10.23%
% of All Funds
1.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
17
Reduced
21
Closed
16
Calls
Puts
Net Calls
Net Calls Change

EIS Hedge Fund Activity: Q1 2022 in Review

79 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in iShares MSCI Israel ETF (EIS) for Q1 2022, worth a combined $58.3M — down 18% from $70.8M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of EIS and 8 opened new positions — a net loss of 8 holders — while 21 trimmed existing stakes and 17 added.

The largest buyer was Jane Street, adding an estimated $2.74M. The largest seller was Ameriprise, exiting entirely with an estimated $2.75M sold.

  • 79 institutional investors held iShares MSCI Israel ETF (EIS) as of Q1 2022, down from 88 in Q4 2021.
  • Funds reported $58.3M of iShares MSCI Israel ETF stock for Q1 2022, down 18% quarter-over-quarter.
  • 8 funds opened new iShares MSCI Israel ETF positions in Q1 2022 and 16 closed out, a net change of -8 holders.
  • The largest iShares MSCI Israel ETF buyer in Q1 2022 was Jane Street, an estimated $2.74M added.
  • The largest iShares MSCI Israel ETF seller in Q1 2022 was Ameriprise, an estimated $2.75M sold.

Based on aggregated 13F filings for Q1 2022.